These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12176458)

  • 1. Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus.
    Daly I; Jain A; Reyes J; Fung J
    Transplant Proc; 2002 Aug; 34(5):1503. PubMed ID: 12176458
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycophenolate mofetil rescue therapy in patients with chronic hepatic allograft rejection.
    Kato T; Ruiz P; DeFaria W; Weppler D; Khan F; Pinna A; Nery J; Tzakis A
    Transplant Proc; 1999; 31(1-2):396. PubMed ID: 10083158
    [No Abstract]   [Full Text] [Related]  

  • 3. Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations.
    Jain A; Kashyap R; Kramer D; Dodson F; Hamad I; Starzl TE; Fung JJ
    Transplant Proc; 2001; 33(1-2):1342-4. PubMed ID: 11267319
    [No Abstract]   [Full Text] [Related]  

  • 4. FK 506 and mycofenolate mofetil rescue for acute steroid-resistant and chronic rejection after liver transplantation.
    Platz KP; Mueller AR; Neuhaus R; Keck HH; Lobeck H; Neuhaus P
    Transplant Proc; 1997 Nov; 29(7):2872-4. PubMed ID: 9365598
    [No Abstract]   [Full Text] [Related]  

  • 5. Indications for mycophenolate mofetil therapy in hepatitis C-patients undergoing liver transplantation.
    Platz KP; Mueller AR; Willimski C; Mansoorian B; Berg T; Neuhaus R; Hopf U; Lobeck H; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1468-9. PubMed ID: 9636596
    [No Abstract]   [Full Text] [Related]  

  • 6. Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantation.
    Klupp J; Glanemann M; Bechstein WO; Platz KP; Langrehr JM; Keck H; Settmacher U; Radtke C; Neuhaus R; Neuhaus P
    Transplant Proc; 1999; 31(1-2):1113-4. PubMed ID: 10083497
    [No Abstract]   [Full Text] [Related]  

  • 7. Replacement of corticosteroids by mycophenolate mofetil in liver graft recipients on initial tacrolimus immunosuppression.
    Ringe B; Braun F; Wietzke P; Oellerich M; Ramadori G
    Transplant Proc; 2000 Nov; 32(7):2543. PubMed ID: 11120285
    [No Abstract]   [Full Text] [Related]  

  • 8. Mycophenolate mofetil rescue therapy in liver transplant recipients: an extended follow-up.
    Gavlik A; Demirbas A; Tsaroucha A; Webb MG; Nery JR; Khan MF; Karatzas T; Khan RT; Zucker K; Viciana AL; Miller JA; Tzakis AG
    Transplant Proc; 1997 Nov; 29(7):2971-2. PubMed ID: 9365633
    [No Abstract]   [Full Text] [Related]  

  • 9. Significance of mycophenolate mofetil treatment in patients with HCV reinfection after liver transplantation: impact on clinical course and histologic damage.
    Bahra M; Neumann UP; Harren M; Jacob D; Langrehr JM; Berg T; Neuhaus R; Neuhaus P
    Transplant Proc; 2002 Nov; 34(7):2934-5. PubMed ID: 12431663
    [No Abstract]   [Full Text] [Related]  

  • 10. A "steroid-free" tacrolimus and low-dose mycophenolate mofetil primary immunosuppression does not prevent early acute rejection after liver transplantation.
    Reggiani P; Arru M; Regazzi M; Gatti S; Molinaro MD; Caccamo L; Maggi U; Melada E; Paone G; Rossi G
    Transplant Proc; 2005 May; 37(4):1697-9. PubMed ID: 15919435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation.
    Eckhoff DE; McGuire BM; Frenette LR; Contreras JL; Hudson SL; Bynon JS
    Transplantation; 1998 Jan; 65(2):180-7. PubMed ID: 9458011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil rescue therapy in liver transplant recipients.
    Gavlik A; Goldberg MG; Tsaroucha A; Webb MG; Khan RT; Weppler D; Nery JR; Khan MF; Zucker K; Viciana AL; Miller JA; Tzakis AG
    Transplant Proc; 1997; 29(1-2):549-52. PubMed ID: 9123124
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil.
    Ringe B; Braun F; Schütz E; Füzesi L; Lorf T; Canelo R; Oellerich M; Ramadori G
    Transplantation; 2001 Feb; 71(4):508-15. PubMed ID: 11258429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction with basiliximab reduces acute rejection in pediatric liver transplant patients treated with tacrolimus and steroids.
    Asensio M; Margarit C; Chavez R; Ortega J; Charco R; Iglesias J
    Transplant Proc; 2002 Aug; 34(5):1970-1. PubMed ID: 12176650
    [No Abstract]   [Full Text] [Related]  

  • 15. How to handle mycophenolate mofetil in combination with tacrolimus?
    Braun F; Canelo R; Schütz E; Shipkora M; Lorf T; Hanack U; Niedmann D; Armstrong VW; Oellerich M; Ringe B
    Transplant Proc; 1998 Dec; 30(8):4094-5. PubMed ID: 9865309
    [No Abstract]   [Full Text] [Related]  

  • 16. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection.
    Theruvath TP; Saidman SL; Mauiyyedi S; Delmonico FL; Williams WW; Tolkoff-Rubin N; Collins AB; Colvin RB; Cosimi AB; Pascual M
    Transplantation; 2001 Jul; 72(1):77-83. PubMed ID: 11468538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indications for mycofenolate mofetil therapy after liver transplantation.
    Platz KP; Mueller AR; Neuhaus P
    Transplant Proc; 1997 Nov; 29(7):2880-1. PubMed ID: 9365601
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapamycin-based rescue therapy after chronic rejection in a pediatric liver transplant patient.
    Iglesias J; Ortega J; López JA; Sánchez L; Allende E; Asensio M; Margarit C
    Transpl Int; 2003 Oct; 16(10):765-7. PubMed ID: 12827229
    [No Abstract]   [Full Text] [Related]  

  • 19. New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus.
    Hunt SA
    Cardiol Rev; 2000; 8(3):180-4. PubMed ID: 11174892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of chronic rejection after treatment failure with FK506 and RS61443.
    Roberts JP; Lake JR; Hebert M; Nikolai B; Ascher NL; Ferrell LD
    Transplantation; 1993 Oct; 56(4):1021-3. PubMed ID: 7692634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.